Effect of functional power training on the walking ability of children with spastic cerebral palsy in the age of 4 to 10 years

Effect of functional power training on the walking ability of children with spastic cerebral palsy in the age of 4 to 10 years - MegaPower training

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON40459

Enrollment

Registered

2013-10-16

Start date

2013-11-19

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'Spastic Cerebral Palsy' 'spastic child'

Interventions

The functional power training (MegaPower training) has three elements: 1. warming-up (10 min), 2. power training (35 min), 3. play (15 min). Key elements of the power training are

a.) functional loaded, muti-joint exercises like running and walking with focus on the push-off, b) the velocity of the movement during the exercises is the same velocity as used in daily/playing a

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Children with diagnosis of predominantly spastic type of Cerebral Palsy, aged 4-10 years, being ambulant without assistive devices (GMFCS level I and II). Parents and/or the children want to improve the walking ability of the child. The children are able to follow instructions to perform the exercises and tests.

Exclusion criteria

Exclusion criteria: Treatment with botulinum toxin A in lower limb or serial casting of lower limb less than 6 months before the MegaPower training starts. Treatment of selective dorsal rhizotomie less than 12 months before the MegaPower training starts. Walking is not (yet) the preferred way to move around.

Design outcomes

Primary

Measure	Time frame
Primary study parameters; The objective primary outcome to measure the effect of the MegaPower training is the Muscle Power Sprint Test (MPST). The Goal Attainment Scaling (GAS) is the subjective, reported by the parents, primary outcome. The MPST is a 6 times 15 meter sprint test. Between the 6 sprints is a 10 sec break in which the child can turn and be ready for the next sprint. The time used for each sprint is measured with 0.01 second precision. Together with body height and weight power will be calculated and expressed in Watts. The MPST measures the anaerobic capacity of the child expressed in mean power and peak power. The reliability of the test is good (ICC=0.97). With GAS the extent of reaching the treatment goal will be measured. GAS is a sensitive, individual, evaluative measurement which describes the change of individuals or groups after treatment (ICC = 0.86).	—

Measure

Time frame

Primary study parameters; The objective primary outcome to measure the effect of the MegaPower training is the Muscle Power Sprint Test (MPST). The Goal Attainment Scaling (GAS) is the subjective, reported by the parents, primary outcome. The MPST is a 6 times 15 meter sprint test. Between the 6 sprints is a 10 sec break in which the child can turn and be ready for the next sprint. The time used for each sprint is measured with 0.01 second precision. Together with body height and weight power will be calculated and expressed in Watts. The MPST measures the anaerobic capacity of the child expressed in mean power and peak power. The reliability of the test is good (ICC=0.97). With GAS the extent of reaching the treatment goal will be measured. GAS is a sensitive, individual, evaluative measurement which describes the change of individuals or groups after treatment (ICC = 0.86).

—

Secondary

Measure	Time frame
Secondary study parameters The secondary study parameters on the activity and participation level of the ICF-CY are the 1 Minute Walk Test (1MWT), 10 meter Shuttle Run Test, the Functional Mobility Scale (FMS), the Mobility questionnaire (MoVra28), Gross Motor Function Measure Dimension D and E (GMFM D&E), and the comfortable walking speed determined during the gait analysis. The 1 MWT measures the distance walked in 1 minute. The children are asked to walk as fast as possible without running. The reliability is good (ICC=0.89 (4-5 year old children with CP), en ICC=0.94 (6-10 year old with CP). Aerobic capacity will be measured with the 10 meter Shuttle Run Test made for children with CP GMFCS level I and II (Reliability: ICC = 0.97 tot 0.99). The FMS is a questionnaire to classify the functional mobility in children with CP in the age of 4 till 18 years old (Reliability: Kappa 0.86-0.92). The MoVra28 is a questionnaire for children from 2-13 years old to determine the extent of problems the child has with his ambulation. The test contains 28 questions about daily activities and has a good reliability (ICC 0.87-0.99). Gross motor function such as standing on one leg, walking and turning, running and jumping are measured in a standardized way with the GMFM D&E (ICC 0.87-0.99). The secondary outcome measures in terms of body function and structures are isometric muscle strength of the calf muscles, quadriceps and abductors and dynamic muscle strength of the calf muscles. The isometric muscle strength is measured with a hand-held dynamometer (microFET Hand-held Dynamometer, Biometrics BV, Almere) (ICC 0.79 - 0.96). The dynamic muscle strength will be measured with the unilateral heel-rise test (ICC 0.86 - 0.98). During gait analysis the peak knee angle in Mid Stance and Terminal Stance will be determined by observing the two and three dimensional video recordings (ICC 0.85-0.96). The Maximum Voluntary Contraction will be assessed with the el	—

Measure

Time frame

Secondary study parameters The secondary study parameters on the activity and participation level of the ICF-CY are the 1 Minute Walk Test (1MWT), 10 meter Shuttle Run Test, the Functional Mobility Scale (FMS), the Mobility questionnaire (MoVra28), Gross Motor Function Measure Dimension D and E (GMFM D&E), and the comfortable walking speed determined during the gait analysis. The 1 MWT measures the distance walked in 1 minute. The children are asked to walk as fast as possible without running. The reliability is good (ICC=0.89 (4-5 year old children with CP), en ICC=0.94 (6-10 year old with CP). Aerobic capacity will be measured with the 10 meter Shuttle Run Test made for children with CP GMFCS level I and II (Reliability: ICC = 0.97 tot 0.99). The FMS is a questionnaire to classify the functional mobility in children with CP in the age of 4 till 18 years old (Reliability: Kappa 0.86-0.92). The MoVra28 is a questionnaire for children from 2-13 years old to determine the extent of problems the child has with his ambulation. The test contains 28 questions about daily activities and has a good reliability (ICC 0.87-0.99). Gross motor function such as standing on one leg, walking and turning, running and jumping are measured in a standardized way with the GMFM D&E (ICC 0.87-0.99). The secondary outcome measures in terms of body function and structures are isometric muscle strength of the calf muscles, quadriceps and abductors and dynamic muscle strength of the calf muscles. The isometric muscle strength is measured with a hand-held dynamometer (microFET Hand-held Dynamometer, Biometrics BV, Almere) (ICC 0.79 - 0.96). The dynamic muscle strength will be measured with the unilateral heel-rise test (ICC 0.86 - 0.98). During gait analysis the peak knee angle in Mid Stance and Terminal Stance will be determined by observing the two and three dimensional video recordings (ICC 0.85-0.96). The Maximum Voluntary Contraction will be assessed with the el

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)